# Zestra in Women With Mixed Sexual Dysfunction

> **NCT00118495** · PHASE3 · COMPLETED · sponsor: **QualiLife Pharmaceuticals** · enrollment: 200 (—)

## Conditions studied

- Sexual Dysfunction, Psychological

## Interventions

- **DRUG:** Non-prescription Zestra(TM): patented formulation

## Key facts

- **NCT ID:** NCT00118495
- **Lead sponsor:** QualiLife Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 200 (—)
- **Last updated:** 2007-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118495, "Zestra in Women With Mixed Sexual Dysfunction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00118495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*